Summary of COVID-19 medicines recommendations from professional bodies

A variety of professional bodies have created guidance and advice on treatment during the COVID-19 pandemic.

A list of links is presented below. We’ll be keeping this page up-to-date over the coming weeks and months and will add summaries for key guidance in the next few days where we can.

If you think we have missed anything or something needs updating, please email

Please note that we are not responsible for the content on external sites and listing these resources should not be taken as an endorsement by SPS of any kind.

Clinical/Therapeutic area Organisation Information type
Addiction Society for the Study of Addiction Links to national guidance, treatment services,  and harm reduction services.
Cancer Cancer Research UK Patient Information
Cardiology European Society of Cardiology Position Statement of the ESC Council on Hypertension on ACE-Inhibitors and Angiotensin Receptor Blockers
European Society of Cardiology Clinicians resource hub
British Heart Foundation Patient information
Dermatology P&T Community International Psoriasis Council Statement On The Coronavirus (COVID-19) Outbreak
British Association of Dermatologists Patient information
British Association of Dermatologists Links to national guidance
Endocrinology Society for Endocrinology Adrenal Crisis Information
Gastroenterology British Society of Gastroenterology COVID-19: BSG and BASL advice for healthcare professionals in Gastroenterology and Hepatology
British Society of Gastroenterology Advice on COVID-19 for patients with Gastrointestinal or Liver conditions
European Crohn’s and Colitis Organisation COVID-19 ECCO Taskforce
Crohn’s & Colitis UK Patient information
International organisation for the study of inflammatory bowel disease Guidance
General BMJ Best Practice Guidelines
British Geriatrics Society COVID-19 and medicines advice for older people
North Central London Medicines Optimisation Network Position statement
Royal Pharmaceutical Society Resource hub
NHS England/NHS Improvement Coronavirus guidance for clinicians and NHS managers
HM Government Guidance (Shielding)
General Practice Royal College of General Practitioners Clinical guidance
Royal College of General Practitioners Learning Resource hub
NSAIDs (ibuprofen) NHS Patient information – ibuprofen
NHS England Guidance
Infections British HIV Association Coronavirus (COVID-19) and HIV – Responses to common questions from the British HIV Association (BHIVA)
British Infection Association Links to national guidance, academic publications and professional societies
Intensive care The Faculty of Intensive Care Medicine Clinical guidance
Metabolic British Inherited Metabolic Diseases Group Patient information
Neurology Association of British Neurologists Guidance on the use of disease-modifying therapies in multiple sclerosis in response to the threat of a coronavirus epidemic
Faculty of Pain Medicine Response to concern related to the safety of steroids injected as part of pain procedures during the current COVID-19 virus pandemic
Obstetrics Royal College of Obstericians and Gynaecologists Guidance
UNICEF Statement
Paediatrics Royal College of Paediatrics and Child Health Guidance
Psychiatry Royal College of Psychiatrists Guidance
Renal Kidney Care UK Patient Information
The Renal Association Guidance
Respiratory Asthma UK Patient Information
British Thoracic Society Guidance
Cystic Fibrosis Trust Statement
Rheumatology British Society for Rheumatology Guidance
Sexual health The Faculty of Sexual & Reproductive Healthcare of the Royal College of Obstetricians and Gynaecologists Guidance
Surgical British Transplantation Society Guidance



Coronavirus (COVID-19)